2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017

BACKGROUND: Fosfomycin is among the limited treatment options for carbapenem-resistant Enterobacteriaceae (CRE) infections. Despite its use, prevalence of fosfomycin resistance among CRE in the United States is largely unknown. In 2017, submission of Enterobacteriaceae isolates resistant to ≥1 carba...

Descripción completa

Detalles Bibliográficos
Autores principales: Snayd, Mary, Leung, Vivian, Maloney, Meghan, Durante, Amanda, Macierowski, Bobbie, Noel, Diane, Muyombwe, Anthony, Razeq, Jafar, Banach, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253430/
http://dx.doi.org/10.1093/ofid/ofy210.2049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253430/
http://dx.doi.org/10.1093/ofid/ofy210.2049

Ejemplares similares